PANTERA

📍 Mol, Belgium🗓 Founded 2022👥 27 employees💰 Last funded Sep 2024
Pharmaceutical Manufacturing🌐 pantera-life.com
Website LinkedIn
PanTera aims to secure the large-scale production of actinium-225 (225Ac), one of the most promising alpha-emitting radioisotopes to fight cancers by Targeted RadioTherapy (TRT). By working towards this large-scale production, PanTera’s ultimate goal is to improve the accessibility of future innovative cancer therapy based on 225Ac and theranostics in general.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
1
Belgium
1
Frequently asked questions
Who invested in PANTERA?
PANTERA has 2 investors on record on gritt.io, including 2 early-stage backers.
When did PANTERA last raise funding?
The most recent investment in PANTERA recorded on gritt.io was in September 2024.
When was PANTERA founded?
PANTERA was founded in 2022.
What industry is PANTERA in?
PANTERA operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is PANTERA based?
PANTERA is headquartered in Mol, Belgium.